Onco-sexology program for laryngectomy patients and their partners
Acceptability and Benefits of an Onco-sexology Program for Laryngectomy Patients and Their Partners
This study is trying out a special program to see if it can help laryngectomy patients and their partners feel better about their intimate lives after surgery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 45 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Institut Claudius Regaud Academic / other |
| Locations | 1 site (Toulouse) |
| Trial ID | NCT06517355 on ClinicalTrials.gov |
What this trial studies
This observational pilot study aims to assess the acceptability of an onco-sexology program specifically designed for patients who have undergone total laryngectomy due to ORL cancer and their partners. The study will follow participants for 14 months to evaluate how this program can improve their perception of intimate life. It is a non-interventional study, meaning that it will not alter standard patient management practices. The focus is on understanding the emotional and relational impacts of laryngectomy on patients and their partners.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who are undergoing treatment for ORL cancer with total laryngectomy and have consented to participate.
Not a fit: Patients with co-existing malignant diseases or those unable to comply with the study protocol due to psychological or sociological conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could enhance the quality of intimate relationships for laryngectomy patients and their partners.
How similar studies have performed: While there is limited data on similar onco-sexology programs, the approach is innovative and may provide new insights into the psychosocial aspects of cancer treatment.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: For patients: 1. Patient to be treated for ORL cancer by total (pharyngo)laryngectomy 2. Patient WHO 0-1-2 3. Age greater than or equal to 18 years 4. Patient who has not objected to participation in the study. For partners (if applicable) : 1. Age greater than or equal to 18 years 2. Subject who has not objected to participation in the study. Exclusion Criteria: For patients: 1. Patient with another co-existing malignant disease at the time of inclusion. 2. Any psychological, familial, geographical or sociological condition that does not allow for compliance with the medical follow-up and/or procedures foreseen in the study protocol. 3. Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice). For partners (if applicable): 1\. Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice).
Where this trial is running
Toulouse
- Iuct-O — Toulouse, France (Recruiting)
Study contacts
- Study coordinator: Julienne VIDAL
- Email: vidal.julienne@iuct-oncopole.fr
- Phone: 05 31 15 51 36
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.